Ratings Summary for COZAAR
Overall Patient opinion of COZAAR: 2.4 (not satisfied)
(based on 415 reviews ) (updated May 6, 2025)Ratings by Age Group for COZAAR
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 2 | 4 |
| Age 18 to 24 | 4 | 4.2 |
| Age 25 to 34 | 22 | 4.2 |
| Age 35 to 44 | 53 | 2.1 |
| Age 45 to 54 | 123 | 2.6 |
| Age 55 to 64 | 123 | 2.3 |
| Age 65 to 74 | 52 | 2.2 |
| Age 75 and up | 21 | 1.6 |
Ratings by Sex for COZAAR
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 186 | 2.76881720430108 |
| Female | 221 | 2.09502262443439 |
| Not Specified | 6 | 2.66666666666667 |
Would you like to find reviews for COZAAR taken for a specific reason or resulting in a specific side effect?
Filter Results for COZAAR
FDA Drug Safety Information for COZAAR
Check here for Ask a Patient's Adverse Event Summary for COZAAR based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.
COZAAR (LOSARTAN POTASSIUM): Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. FDA Approval Date: 1998-10-13 (Sources: U.S. Centers for Medicare Services, FDA)
